Review
Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy
Affiliations
- PMID: 12883042
Item in Clipboard
Review
Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy
Mol Cancer Ther.
2003 Jul.
Abstract
The ATP-binding cassette (ABC) transporters belong to the largest known transporter gene family and translocate a variety of substrates including chemotherapy agents. ABC multidrug transporter expression has been implicated in tumor cell resistance to anticancer therapy, altered disposition of chemotherapy drugs, and associated chemotherapy toxicity. More recently, genetic heterogeneity has been described in a number of the ABC transporter genes, including ABC transporters that contribute to the pharmacokinetics and/or pharmacodynamics of chemotherapy drugs. The role of these transporters and their naturally occurring genetic polymorphisms in cancer and chemotherapy is reviewed.
Similar articles
-
Pharmacogenomics of ABC transporters and its role in cancer chemotherapy.Drug Resist Updat. 2003 Apr;6(2):71-84. doi: 10.1016/s1368-7646(03)00005-0. Drug Resist Updat. 2003. PMID: 12729805 Review.
-
ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview.Expert Opin Drug Metab Toxicol. 2016 Dec;12(12):1419-1432. doi: 10.1080/17425255.2016.1215423. Epub 2016 Aug 3. Expert Opin Drug Metab Toxicol. 2016. PMID: 27459275 Review.
-
Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.Expert Opin Drug Metab Toxicol. 2014 Oct;10(10):1337-54. doi: 10.1517/17425255.2014.952630. Epub 2014 Aug 27. Expert Opin Drug Metab Toxicol. 2014. PMID: 25162314 Review.
-
Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug disposition.Curr Drug Targets. 2011 May;12(5):631-46. doi: 10.2174/138945011795378487. Curr Drug Targets. 2011. PMID: 21039333 Review.
-
Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.Pharmacogenomics. 2005 Mar;6(2):115-38. doi: 10.1517/14622416.6.2.115. Pharmacogenomics. 2005. PMID: 15882131 Review.
Cited by
-
Genetic polymorphism of the human organic solute carrier protein 1 (hOSCP1) gene in Japanese patients with non-viral liver carcinoma.Meta Gene. 2014 Oct 1;2:686-93. doi: 10.1016/j.mgene.2014.09.002. eCollection 2014 Dec. Meta Gene. 2014. PMID: 25606452 Free PMC article.
-
The ABCA2 transporter: intracellular roles in trafficking and metabolism of LDL-derived cholesterol and sterol-related compounds.Curr Drug Metab. 2007 Jan;8(1):47-57. doi: 10.2174/138920007779315044. Curr Drug Metab. 2007. PMID: 17266523 Free PMC article. Review.
-
Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant.Br J Clin Pharmacol. 2009 Sep;68(3):413-21. doi: 10.1111/j.1365-2125.2009.03461.x. Br J Clin Pharmacol. 2009. PMID: 19740399 Free PMC article.
-
Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patients.Pharmacogenomics J. 2023 Jul;23(4):73-81. doi: 10.1038/s41397-023-00299-7. Epub 2023 Jan 28. Pharmacogenomics J. 2023. PMID: 36709390
-
Drug efflux by breast cancer resistance protein is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924.Mol Cancer Ther. 2011 Jan;10(1):117-25. doi: 10.1158/1535-7163.MCT-10-0438. Mol Cancer Ther. 2011. PMID: 21220496 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources